Differential Role of p53 in Oligodendrocyte Survival in Response to Various Stresses: Experimental Autoimmune Encephalomyelitis, Cuprizone Intoxication or White Matter Stroke

Int J Mol Sci. 2021 Nov 26;22(23):12811. doi: 10.3390/ijms222312811.

Abstract

Promoting oligodendrocyte viability has been proposed as a therapeutic strategy for alleviating many neuronal diseases, such as multiple sclerosis and stroke. However, molecular pathways critical for oligodendrocyte survival under various stresses are still not well known. p53 is a strong tumor suppressor and regulates cell cycle, DNA repair and cell death. Our previous studies have shown that p53 plays an important role in promoting neuronal survival after insults, but its specific role in oligodendrocyte survival is not known. Here, we constructed the mice with oligodendrocyte-specific p53 loss by crossing TRP53flox/flox mice and CNP-cre mice, and found that p53 was dispensable for oligodendrocyte differentiation and myelin formation under physiological condition. In the experimental autoimmune encephalomyelitis (EAE) model, p53 loss of function, specifically in oligodendrocytes, did not affect the EAE disease severity and had no effect on demyelination in the spinal cord of the mice. Interestingly, p53 deficiency in oligodendrocytes significantly attenuated the demyelination of corpus callosum and alleviated the functional impairment of motor coordination and spatial memory in the cuprizone demyelination model. Moreover, the oligodendrocyte-specific loss of p53 provided protection against subcortical white matter damage and mitigated recognition memory impairment in mice in the white matter stroke model. These results suggest that p53 plays different roles in the brain and spinal cord or in response to various stresses. Thus, p53 may be a therapeutic target for oligodendrocyte prevention in specific brain injuries, such as white matter stroke and multiple sclerosis.

Keywords: cuprizone; inflammation; oligodendrocyte; p53; white matter stroke.

MeSH terms

  • Animals
  • Chelating Agents / toxicity
  • Cuprizone / toxicity*
  • Encephalomyelitis, Autoimmune, Experimental / etiology
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control*
  • Female
  • Leukoencephalopathies / etiology
  • Leukoencephalopathies / metabolism
  • Leukoencephalopathies / pathology
  • Leukoencephalopathies / prevention & control*
  • Male
  • Memory Disorders / etiology
  • Memory Disorders / metabolism
  • Memory Disorders / pathology
  • Memory Disorders / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oligodendroglia / cytology*
  • Oligodendroglia / metabolism
  • Stroke / etiology
  • Stroke / metabolism
  • Stroke / pathology
  • Stroke / prevention & control*
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • Chelating Agents
  • Trp53 protein, mouse
  • Tumor Suppressor Protein p53
  • Cuprizone